159 related articles for article (PubMed ID: 18662145)
1. [Can blockade of the renin-angiotensin system be optimised in proteinuric nephropathies?].
Juárez GF
Nefrologia; 2008; 28(4):381-4. PubMed ID: 18662145
[No Abstract] [Full Text] [Related]
2. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
3. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
4. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
Berl T
Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
[No Abstract] [Full Text] [Related]
5. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
Ku E; Park J; Vidhun J; Campese V
Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
[No Abstract] [Full Text] [Related]
6. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
Gradman AH
Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
[No Abstract] [Full Text] [Related]
7. Aliskiren combined with losartan in diabetes and nephropathy.
Lindner T
N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
[No Abstract] [Full Text] [Related]
8. [Pharmacological differences between inhibitor drugs of the renin-angiotensin aldosterone system].
Méndez-Durán A
Rev Med Inst Mex Seguro Soc; 2011; 49(1):45-52. PubMed ID: 21513660
[TBL] [Abstract][Full Text] [Related]
9. [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].
Legrand D; Krzesinski JM; Scheen AJ
Rev Med Suisse; 2008 Aug; 4(168):1792-7. PubMed ID: 18814762
[TBL] [Abstract][Full Text] [Related]
10. Dual renin-angiotensin system blockade: in patients with single functioning kidney and proteinuria.
Robles NR; Ruiz Jiménez B; Hernández Gallego R; Ruiz-Calero R; Sánchez Casado E; Cubero JJ
Eur J Intern Med; 2009 Mar; 20(2):186-9. PubMed ID: 19327610
[TBL] [Abstract][Full Text] [Related]
11. The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering.
Bidani AK; Griffin KA
Nat Clin Pract Nephrol; 2006 Oct; 2(10):542-3. PubMed ID: 17003827
[No Abstract] [Full Text] [Related]
12. Aliskiren combined with losartan in diabetes and nephropathy.
Anderson S; Komers R
N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
[No Abstract] [Full Text] [Related]
13. Dual blockade of the renin-angiotensin system for cardiorenal protection: an update.
Arici M; Erdem Y
Am J Kidney Dis; 2009 Feb; 53(2):332-45. PubMed ID: 19166800
[TBL] [Abstract][Full Text] [Related]
14. Novel imaging strategies for predicting remodeling and evolution of heart failure: targeting the Renin-Angiotensin system.
Shirani J; Narula J; Eckelman WC; Dilsizian V
Heart Fail Clin; 2006 Apr; 2(2):231-47. PubMed ID: 17386892
[No Abstract] [Full Text] [Related]
15. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL; Townsend RR
J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
[TBL] [Abstract][Full Text] [Related]
16. Acute renal failure associated to renin angiotensin system (RAS) inhibitors--its burden in a nephrology department.
Navarro I; Poveda R; Torras J; Castelao AM; Grinyó JM
Nephrol Dial Transplant; 2008 Jan; 23(1):413-4. PubMed ID: 17890250
[No Abstract] [Full Text] [Related]
17. Combinations of renin-angiotensin-aldosterone system antagonists: true advantages?
Veglio F; Puglisi E; Milan A; Mulatero P
Curr Pharm Des; 2012; 18(7):952-7. PubMed ID: 22283773
[TBL] [Abstract][Full Text] [Related]
18. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
Renke M; Tylicki L; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
Kidney Blood Press Res; 2008; 31(6):404-10. PubMed ID: 19092257
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin antagonists.
Robertson MJ
J Recept Signal Transduct Res; 2000 Nov; 20(4):211-34. PubMed ID: 11192019
[No Abstract] [Full Text] [Related]
20. [The renin-angiotensin system].
Hilgers KF
Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
